Anacor, Drugs for Neglected Diseases initiative, TB Alliance deal

TB Alliance received a non-exclusive, royalty-free, worldwide license to develop an undisclosed anti-bacterial drug target from Anacor to treat tuberculosis. Anacor will receive undisclosed financial support. ...